CLOSOBEL

This brand name is authorized in Nigeria.

Active ingredients

The drug CLOSOBEL contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 826Y60901U - BETAMETHASONE DIPROPIONATE
 

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

 
Read more about Betamethasone
2
UNII G07GZ97H65 - CLOTRIMAZOLE
 

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

 
Read more about Clotrimazole
3
UNII 057Y626693 - NEOMYCIN SULFATE
 

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

 
Read more about Neomycin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-7155 Cream CLOSOBEL CREAM CREAM 0.05%; 1%; 0.5% 1X30G 38 RNW-PP-264118 CLOSOBEL CREAM BETAMETHASONE USP 0.05%W/W, CLOTRIMAZOLE USP 1%W/W, NEOMYCIN SULFATE USP 0.5%W/W CLOTRIMAZOLE 1.0% W/W, BETAMETHASONE DIPROPIONATE 0.05% W/W, NEOMYCIN SULPHATE 0.5% W/W, CHLOROCRESOL 0.1 W/W, CETOSTEARYL ALCOHOL, MACROGOL CETOSTEARYL ETHER, LIQUID PARAFFIN (HEAVY), WHITE SOFT PARAFFIN, PROPYLENE GLYCOL, DISODIUM HYDROGEN PHOSPHATE DIHYDRATE, SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE (SODIUM ACID PHOSPHATE), DISODIUM EDTA, ORTHO PHOSPHORIC ACID, PURIFIED WATER B4-7155 Drugs DERMATOLOGICALS Imported Products 1X30G Prescription Only Medicine (POM) 5/16/2022 ELIONA PHARMACEUTICAL COMPANY LIMITED, No. 6 Akinfenwa street off Celestial Way , Ori-Oke, Ogudu, Lagos. 8145462544 elionapharma@gmail.com GOPALDAS VISRAM & CO. LTD, Plot No A-590/591, MIDC TTC INDUSTRIAL AREA MAHAPE, NAVI MUMBAI - 400 701 MAHARASHTRA INDIA, India 9.71341E+11 28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D07CC01 Betamethasone and antibiotics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-7155

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.